|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06667 MEGA GENOMICS
Nominal 
7.190 +0.020 (+0.279%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 192,499 | 136.831% | 247,150 | 164,226 | 151,300 | 145,727 |
| Cost of Sales | (128,821) | 509.342% | (129,790) | (44,878) | (63,004) | (64,004) |
| Gross Profit | 63,678 | 5.883% | 117,360 | 119,348 | 88,296 | 81,723 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (9,548) | 7,294 | 11,579 | (25,852) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | (15,516) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 30,962 | -6.578% | 32,827 | 53,633 | 36,179 | (21,418) | |
| Taxation | (6,211) | 5.611% | (5,806) | (8,588) | (6,141) | 3,800 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 24,751 | -9.207% | 27,021 | 45,045 | 30,038 | (17,618) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 505 | -- | (102) | 47 | 400 | (667) |
| Depreciation & Amortisation | 7,990 | 6.804% | 15,485 | 14,674 | 15,120 | 15,278 |
| Directors' Emoluments | -- | -- | -- | 5,217 | 8,623 | 6,594 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 12.000 | -7.692% | 14.000 | 22.000 | 14.000 | -9.000 |
| DPS (cts) | 0.000 | -- | 15.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 107.143% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.084) | 0.276 | 0.773 | (0.034) |
| NBV per share ($) | 2.700 | -- | 2.724 | 2.649 | 2.709 | 2.583 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 24,751 |
| %Change | -9.207% |
| EPS / (LPS) | RMB 0.120 |
| NBV Per Share (¥) | RMB 2.700 |